Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US5104653

Title:Use of human interferon-beta for stimulation of erythropoiesis
Inventors:Michalevicz, Rita; Petach Tikvah, Israel
Summary:Described herein are methods for the use of pharmaceutical compositions containing human interferon-? in the stimulation of erythropoieses. The invention relates to low doses of interferon-? in the stimulation of erythropoietic disorders which are characterized by a lack of mature red blood cells. Therapeutic applications are directed toward the treatment of human patients suffering from such disorders in which progenitor blood cells lack the ability to mature to red blood cells. Methods are provided for the administration to the patient of an erythropoietic effective amount of human interferon-?.
Abstract:Interferon-beta, preferably in low doses, is used for stimulation of erythropoiesis in disorders characterized by lack of maturation of progenitor blood cells to red cells.
US Patent Website:Click Here for Full Text of Patent
Title Number:US5104653
Application Number:US1990000495027
Date Filed:16/03/1990
Date Published:14/04/1992
Assignee:Interpharm Laboratories Ltd., Ness-Ziona, Israel Ramot, University Authority for Applied Research and Industrial Development Ltd., Tel-Aviv, Israel


 
Copyright © 2007 The Institute for Cellular Medicine  6/13/2021